Stay updated on Avutometinib and Defactinib in Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page.

Latest updates to the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision badge updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check28 days agoChange DetectedRemoved the government funding operating status notice from the page. The notice previously informed users that information may not be up to date due to funding and system outages.SummaryDifference0.3%

- Check43 days agoChange DetectedExternal informational links to MedlinePlus, NIH/NLM/NCBI, MSKCC, and government sites were removed from the page. These links were supplementary and not part of the core study details.SummaryDifference0.5%

- Check71 days agoChange DetectedCore content updated with an operational status notice and a new version (v3.2.0); previous version (v3.1.0) removed.SummaryDifference3%

- Check79 days agoChange DetectedMajor contact/name and metadata updates: old contact David Pfister, MD and older revision/date replaced with Eric Sherman, MD and new contact numbers, plus updated last-update and revision version.SummaryDifference1%

- Check93 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2. Removed the 'Back to Top' element.SummaryDifference0.2%

Stay in the know with updates to Avutometinib and Defactinib in Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page.